Core Viewpoint - Baiyang Pharmaceutical's brand DQIAO has launched a new liquid glucosamine calcium product targeting middle-aged consumers' joint and bone health management, continuing its innovation in the calcium nutrition sector [1] Group 1: Product Launch and Market Position - The new product, SJJ, is set to be released in 2025 and focuses on the health management of joints and bones for new middle-aged consumers [1] - DQIAO has maintained its position as the number one imported calcium supplement brand in China for nine consecutive years [1] - The product is currently being produced in South Korea, indicating a global production chain established by the company [1]